A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adaani E Frost, M.D.
Baylor College of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Vincent'S Hospital
Darlinghurst, New South Wales, Australia
- the Prince Charles Hospital
Chermside, Queensland, Australia
- Royal Hobart Hospital
Hobart, Tasmania, Australia
- the Alfred Hospital
Melbourne, Victoria, Australia
- Gottsegen Gyorgy Hungarian
Budapest, Hungary
- Semmelweis Karlocai
Budapest, Hungary
- University of Debrecen
Debrecen, Hungary
- University of Szeged
Szeged, Hungary
- Ucsd Medical Center
La Jolla, California, United States
- Ucla Medical Center
Torrance, California, United States
- University of Colorado Denver
Aurora, Colorado, United States
- Kentuckiana Pulmonary Associates
Louisville, Kentucky, United States
- University of Maryland Medical Center
Baltimore, Maryland, United States
- Boston University School of Medicine
Boston, Massachusetts, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- the Ohio State University Medical Center
Columbus, Ohio, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
- Inova Fairfax Hospital
Falls Church, Virginia, United States
- Aurora St. Luke'S Medical Center
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2012
- Primary completion
- 28 Feb 2014
- Completion
- 28 Feb 2014
- Last update posted
- 9 Apr 2014
- Registered enrollment
- 29
- Registry id
- NCT01725256
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.